FDA Alerts

FDA Alerts
FDA Alerts
U.S. Food & Drug Administration
11/03/2016
The FDA makes its website accessible for the widest possible audience to get up to date information and alerts.
11/03/2016
Disease Prevention
Disease Prevention
FDA Approves New Device for the Prevention of Strokes
10/31/2016
The FDA approved the Amplatzer PFO Occluder device to reduce stroke risk in patients who have had a stroke from a blood clot passing through a patent foramen ovale.
10/31/2016
FDA Alerts
FDA Alerts
FDA Adds New Warning to Testosterone Label
10/26/2016
The FDA has approved class-wide labeling changes for all prescription testosterone products with information regarding the risks of abuse and dependence.
10/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Age-Related Macular Degeneration
10/17/2016
The FDA approved a new method of administering treatment for patients with wet age-related macular degeneration and macular edema following retinal vein occlusion.
10/17/2016
FDA Alerts
FDA Alerts
FDA Approves New Quadrivalent Flu Vaccine
10/11/2016
The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.
10/11/2016
FDA Alerts
FDA Alerts
FDA Approves New Low Dose Option for Opioid Dependence
10/06/2016
The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.
10/06/2016
FDA Alerts
FDA Alerts
FDA: Monitor Hep C Patients for Hep B Reactiviation
10/04/2016
The US Food and Drug Administration is now requiring a Boxed Warning be added to the drug labels of certain direct-acting antiviral medicines used for the treatment of hepatitis C.
10/04/2016
FDA
FDA
FDA Warns Against Use of Homeopathic Teething Tablets and Gels               
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA Alerts
FDA Alerts
FDA Approves Artificial Pancreas
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Crohn Disease
09/26/2016
The FDA approved a biologic to treat adults with active Crohn disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids.
09/26/2016